 This study will determine in obese subjects the direct effects of the weight loss drug rimonabant ie independent of weight loss on energy expenditure, fat metabolism and and body fat distribution. We hypothesise that rimonabant will increase energy expenditure. The fuel for the increased energy expenditure will come from fat. As a result of burning more fat there will be a decrease in fat in blood and an improvement in the bodys response to insulin. 